A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Amyloid plaques (depicted in orange) are a central feature of Alzheimer's disease in the brain. A ...

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer's disease ...

"Going after a few diseases, where Alzheimer's is number one by quite a bit, the imperative is very, very clear," Gates added ...

The roadmap to fighting Alzheimer’s disease is a matter of updating government policy to match the current science.

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...

The U.S. Food and Drug Administration (FDA) recently cleared a blood test that detects signs of Alzheimer's disease in the brain, according to multiple studies. This is the first-ever blood test ...